Trials / Completed
CompletedNCT00138502
Funguria in Hospitalized Patients
The Significance of Funguria In Hospitalized Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 926 (planned)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID) · NIH
- Sex
- All
- Age
- 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
Detailed description
This protocol will attempt to generate a detailed clinical profile of patients with funguria and identify subgroups of patients with funguria at high risk for candiduria and determine the relative risks for obtaining candiduria. In addition, it will look at identifying subgroups of patients with funguria at high risk for candidemia and identifying subgroups of patients with funguria at high risk for death. Finally, it will attempt to determine if funguria independently predicts fungemia or death. Data will be complemented by surveillance of a comparable population without funguria.
Conditions
Timeline
- Start date
- 2001-09-17
- Primary completion
- 2008-12-08
- Completion
- 2008-12-08
- First posted
- 2005-08-30
- Last updated
- 2019-02-04
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00138502. Inclusion in this directory is not an endorsement.